O
OrbiMed’s Gilead Sciences GILD Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | – | Sell |
-197,500
| Closed | -$22.1M | – | 102 |
|
2025
Q1 | $22.1M | Sell |
197,500
-48,100
| -20% | -$5.39M | 0.53% | 40 |
|
2024
Q4 | $22.7M | Buy |
245,600
+93,900
| +62% | +$8.67M | 0.47% | 48 |
|
2024
Q3 | $12.7M | Buy |
+151,700
| New | +$12.7M | 0.23% | 74 |
|
2024
Q1 | – | Sell |
-100,000
| Closed | -$8.1M | – | 116 |
|
2023
Q4 | $8.1M | Hold |
100,000
| – | – | 0.16% | 81 |
|
2023
Q3 | $7.49M | Hold |
100,000
| – | – | 0.16% | 89 |
|
2023
Q2 | $7.71M | Buy |
+100,000
| New | +$7.71M | 0.14% | 92 |
|
2022
Q3 | – | Sell |
-287,600
| Closed | -$17.8K | – | 133 |
|
2022
Q2 | $17.8K | Hold |
287,600
| – | – | 0.32% | 67 |
|
2022
Q1 | $17.1M | Hold |
287,600
| – | – | 0.28% | 73 |
|
2021
Q4 | $20.9M | Hold |
287,600
| – | – | 0.27% | 83 |
|
2021
Q3 | $20.1M | Hold |
287,600
| – | – | 0.22% | 96 |
|
2021
Q2 | $19.8M | Hold |
287,600
| – | – | 0.2% | 100 |
|
2021
Q1 | $18.6M | Buy |
287,600
+95,400
| +50% | +$6.17M | 0.17% | 101 |
|
2020
Q4 | $11.2M | Hold |
192,200
| – | – | 0.1% | 119 |
|
2020
Q3 | $12.1M | Hold |
192,200
| – | – | 0.15% | 102 |
|
2020
Q2 | $14.8M | Sell |
192,200
-1,278,900
| -87% | -$98.4M | 0.21% | 86 |
|
2020
Q1 | $110M | Buy |
1,471,100
+1,145,000
| +351% | +$85.6M | 1.85% | 15 |
|
2019
Q4 | $21.2M | Hold |
326,100
| – | – | 0.3% | 65 |
|
2019
Q3 | $20.7M | Sell |
326,100
-75,500
| -19% | -$4.79M | 0.39% | 62 |
|
2019
Q2 | $27.1M | Sell |
401,600
-42,200
| -10% | -$2.85M | 0.42% | 56 |
|
2019
Q1 | $28.9M | Hold |
443,800
| – | – | 0.45% | 56 |
|
2018
Q4 | $27.8M | Buy |
443,800
+79,200
| +22% | +$4.95M | 0.51% | 57 |
|
2018
Q3 | $28.2M | Hold |
364,600
| – | – | 0.34% | 77 |
|
2018
Q2 | $25.8M | Hold |
364,600
| – | – | 0.31% | 71 |
|
2018
Q1 | $27.5M | Sell |
364,600
-157,000
| -30% | -$11.8M | 0.34% | 69 |
|
2017
Q4 | $37.4M | Sell |
521,600
-1,406,400
| -73% | -$101M | 0.47% | 61 |
|
2017
Q3 | $156M | Sell |
1,928,000
-145,400
| -7% | -$11.8M | 1.49% | 22 |
|
2017
Q2 | $147M | Buy |
2,073,400
+1,272,500
| +159% | +$90.1M | 1.54% | 21 |
|
2017
Q1 | $54.4M | Sell |
800,900
-254,200
| -24% | -$17.3M | 0.62% | 50 |
|
2016
Q4 | $75.6M | Sell |
1,055,100
-955,600
| -48% | -$68.4M | 0.96% | 34 |
|
2016
Q3 | $159M | Sell |
2,010,700
-1,062,200
| -35% | -$84M | 1.81% | 17 |
|
2016
Q2 | $256M | Buy |
3,072,900
+53,700
| +2% | +$4.48M | 2.67% | 9 |
|
2016
Q1 | $277M | Sell |
3,019,200
-402,200
| -12% | -$36.9M | 2.92% | 9 |
|
2015
Q4 | $346M | Buy |
3,421,400
+1,237,000
| +57% | +$125M | 3.14% | 10 |
|
2015
Q3 | $214M | Sell |
2,184,400
-711,000
| -25% | -$69.8M | 2.17% | 14 |
|
2015
Q2 | $339M | Sell |
2,895,400
-516,000
| -15% | -$60.4M | 2.83% | 10 |
|
2015
Q1 | $335M | Sell |
3,411,400
-838,100
| -20% | -$82.2M | 2.86% | 6 |
|
2014
Q4 | $401M | Buy |
4,249,500
+487,300
| +13% | +$45.9M | 3.83% | 5 |
|
2014
Q3 | $400M | Buy |
3,762,200
+327,400
| +10% | +$34.9M | 4.18% | 1 |
|
2014
Q2 | $285M | Sell |
3,434,800
-1,880,000
| -35% | -$156M | 3.34% | 5 |
|
2014
Q1 | $377M | Buy |
5,314,800
+322,200
| +6% | +$22.8M | 4.63% | 2 |
|
2013
Q4 | $375M | Buy |
4,992,600
+214,800
| +4% | +$16.1M | 5.51% | 1 |
|
2013
Q3 | $300M | Sell |
4,777,800
-44,000
| -0.9% | -$2.77M | 5.36% | 1 |
|
2013
Q2 | $247M | Buy |
+4,821,800
| New | +$247M | 5.24% | 2 |
|